Sexual function of patients under surveillance for bladder cancer

BJU International

Volumn 104, Issue 1, 2009, Pages 35-40

  Van Der Aa, Madelon N M ^a,b   Bekker, Milou D ^a   Van Der Kwast, Theo H ^b,d   Essink Bot, Marie Louise ^c   Steyerberg, Ewout W ^b   Zwarthoff, Ellen C ^b   Sen, Fatma E F ^b   Elzevier, Henk W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Non muscle invasive bladder cancer; Sexual function; Surveillance; Urothelial cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTOSCOPY; DEMOGRAPHY; FEMALE; HEALTH STATUS; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL INTERCOURSE; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CYSTOSCOPY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LIBIDO; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUAL PARTNERS; URINARY BLADDER NEOPLASMS;

EID: 67650497777     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08333.x     Document Type: Article

References (30)

1. Sengupta N, Siddiqui E, Mumtaz FH. Cancers of the bladder. J R Soc Health 2004 124 : 228 9
2. Allard P, Bernard P, Fradet Y, Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 1998 81 : 692 8
3. Witjes JA, Melissen DO, Kiemeney LA. Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey. Eur Urol 2006 49 : 478 84
4. Botteman MF, Pashos CI, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003 21 : 1315 30
5. Wright MP, Jones DJ. Surveillance for bladder cancer: the management of 4.8 million people. South-West Urologists. BJU Int 2000 85 : 431 3
6. Mariappan P, Smith G. surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. J Urol 2005 173 : 1108 11
7. Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 1995 33 : 828 41
8. Van Der Aa MN, Steyerberg EW Sen EF et al. Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison. BJU Int 2008 101 : 1106 10
9. Vriesema JI, Poucki MH, Kiemeney LA, Witjes JA. Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis. Urology 2000 56 : 793 7
10. Muezzinoglu T, Ceylan Y, Temeltas G, Lekili M, Buyuksu C. Evaluation of pain caused by urethrocystoscopy in patients with superficial bladder cancer: a perspective of quality of life. Onkologie 2005 28 : 260 4
11. Kortmann BB, Sonke GS, D'Ancona FC, Floratos DI, Debruyne FM, De La Rosette JJ. The tolerability of urodynamic studies and flexible cysto-urethroscopy used in the assessment of men with lower urinary tract symptoms. BJU Int 1999 84 : 449 53
12. Denholm SW, Conn IG, Newsam JE, Chisholm GD. Morbidity following cystoscopy: comparison of flexible and rigid techniques. Br J Urol 1990 66 : 152 4
13. Herr HW, Schneider M. Outpatient flexible cystoscopy in men: a randomized study of patient tolerance. J Urol 2001 165 : 1971 2
14. Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer 2006 106 : 2355 62
15. Elzevier HW, Nieuwkamer BB, Pelger RC. Lycklama a Nijeholt AA. Female sexual function and activity following cystectomy and continent urinary tract diversion for benign indications: a clinical pilot study and review of literature. J Sex Med 2007 4 : 406 16
16. Stav K, Leibovici D, Goren E et al. Adverse effects of cystoscopy and its impact on patients' quality of life and sexual performance. Isr Med Assoc J 2004 6 : 474 8
17. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007 357 : 762 74
18. Beutel ME, Weidner W, Brahler E. Epidemiology of sexual dysfunction in the male population. Andrologia 2006 38 : 115 21
19. Wallerand H, Bakkar AA, DeMedina SG et al. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Carcinogenesis 2005 26 : 177 84
20. Brennan P, Bogillot O, Cordier S et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000 86 : 289 94
21. Harte CB, Meston CM. The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: results from a randomized, double-blind, placebo-controlled, cross-ver trial. J Sex Med 2008 5 : 1184 97
22. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999 281 : 537 44
23. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology 2004 64 : 991 7
24. Lewis RW, Fugl-Meyer KS, Bosch R et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004 1 : 35 9
25. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005 47 : 80 6
26. Rosen R, Altwein J, Boyle P et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003 44 : 637 49
27. Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the true prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med 2008 5 : 777 87
28. Diblasio C, Malcolm J, Derweesh I et al. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer. BJU Int 2008 102 : 39 43 (Pubitemid 351799441)
29. Mandras SA, Uber PA, Mehra MR. Sexual activity and chronic heart failure. Mayo Clin Proc 2007 82 : 1203 10
30. Melo Ade S, Carvalho EC, Pela NT. The sexuality of patients with onco-hematological diseases. Rev Lat Am Enfermagem 2006 14 : 227 32